— Tandem Diabetes (NASDAQ: TNDM) reported earnings of $0.04 per share in the fourth quarter of 2019, vs $0.05 per share loss expected
— Q4 Sales grew 42% to $108.4 million, vs. $109.2 million expected
— Worldwide pump shipments increased 21% to 19,602 pumps in Q4
— For FY20, sales are estimated to be in the range of $450 million to $465 million, up 24% to 28%. Adjusted EBITDA is estimated to be 12% to 14%
— TNDM fell 3.8% immediately following the announcement.
Most Popular
Mattel (MAT): A look at the toymaker’s expectations for the year
Shares of Mattel, Inc. (NASDAQ: MAT) were up slightly on Thursday. The stock has gained 20% year-to-date and 19% over the past three months. There is a level of optimism
Earnings Preview: Paychex likely to report higher Q1 revenue and profit
Paychex Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is all set to publish operating results for the first three months of fiscal 2024. The company has
DRI Earnings: Key quarterly highlights from Darden Restaurants’ Q1 2024 financial results
Darden Restaurants, Inc. (NYSE: DRI) reported first quarter 2024 earnings results today. Total sales increased 11.6% to $2.73 billion compared to the same period last year. Blended same-restaurant sales were
